Discounted Cash Flow
Fulgent Genetics, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $18.3m | $-5.3m | $617.0k | -29.3% | — |
| 2017 | $18.7m (2.5%) | $-2.5m (53.1%) | $-1.6m (-353.5%) | -13.4% (54.2%) | — |
| 2018 | $21.4m (14.0%) | $-5.6m (-123.4%) | $-3.0m (-91.6%) | -26.3% (-96.0%) | — |
| 2019 | $32.5m (52.3%) | $-411.0k (92.7%) | $-411.0k (86.3%) | -1.3% (95.2%) | — |
| 2020 | $421.7m (1196.5%) | $214.3m (52243.6%) | $105.5m (25768.6%) | 50.8% (4122.0%) | — |
| 2021 | $992.6m (135.4%) | $507.4m (136.7%) | $514.8m (387.9%) | 51.1% (0.6%) | — |
| 2022 | $619.0m (-37.6%) | $143.4m (-71.7%) | $234.7m (-54.4%) | 23.2% (-54.7%) | — |
| 2023 | $289.2m (-53.3%) | $-167.8m (-217.0%) | $4.8m (-98.0%) | -58.0% (-350.5%) | — |
| 2024 | $283.5m (-2.0%) | $-42.7m (74.6%) | $-19.3m (-501.5%) | -15.1% (74.0%) | — |
| 2025 | $322.7m (13.8%) | $-60.5m (-41.7%) | $-124.2m (-545.1%) | -18.8% (-24.5%) | — |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.